Parkinson's Disease

Gut dysbiosis in Parkinson’s disease 1:02
Gut dysbiosis in Parkinson’s disease
Brit Mollenhauer • 24 Sep 2021
Microbiome to elucidate Parkinson’s disease 4:41
Microbiome to elucidate Parkinson’s disease
Paul Wilmes • 5 Oct 2021
Nutritional intervention studies to influence the gut microbiome and improve Parkinson’s disease 3:10
Nutritional intervention studies to influence the gut microbiome and improve Parkinson’s disease
Brit Mollenhauer • 24 Sep 2021
New research looking into disease modifying treatments for atypical parkinsonism 2:32
New research looking into disease modifying treatments for atypical parkinsonism
Irene Litvan • 22 Sep 2021
How does exercise slow progression in Parkinson’s disease? 1:56
How does exercise slow progression in Parkinson’s disease?
Daniel Corcos • 23 Sep 2021
Movement disorders: is searching for a cure hindering the development of symptomatic treatments? 2:16
Movement disorders: is searching for a cure hindering the development of symptomatic treatments?
Alfonso Fasano • 22 Sep 2021
Phase III SPARX3 trial of moderate- vs. high-intensity exercise to slow progression in PD 4:37
Phase III SPARX3 trial of moderate- vs. high-intensity exercise to slow progression in PD
Daniel Corcos • 23 Sep 2021
Advances in the diagnosis of atypical parkinsonism 3:58
Advances in the diagnosis of atypical parkinsonism
Irene Litvan • 22 Sep 2021
The future of imaging in Parkinson’s disease 1:51
The future of imaging in Parkinson’s disease
Sofia Reimão • 20 Sep 2021
The impact of LCIG on dyskinesia duration & severity in PD 4:19
The impact of LCIG on dyskinesia duration & severity in PD
Alfonso Fasano • 22 Sep 2021
Genetic testing for Parkinson’s disease in clinical practice 2:27
Genetic testing for Parkinson’s disease in clinical practice
Oscar Gershanik • 16 Sep 2021
Upcoming treatments for Parkinson’s disease 1:10
Upcoming treatments for Parkinson’s disease
Zvezdan Pirtosek • 27 Sep 2021
Verbal skills and neurodegeneration 3:38
Verbal skills and neurodegeneration
Adolfo Garcia • 20 Sep 2021
Novel targets for Parkinson’s disease: thinking beyond the status quo 2:27
Novel targets for Parkinson’s disease: thinking beyond the status quo
Lars Wojtecki • 28 Sep 2021
Parkinson’s disease: what’s to come in 2022? 3:20
Parkinson’s disease: what’s to come in 2022?
Angelo Antonini • 24 Sep 2021
The future of Parkinson’s disease treatments 1:24
The future of Parkinson’s disease treatments
Lars Wojtecki • 28 Sep 2021
The content of VJNeurology is intended for healthcare professionals